Search
for
Sort by
Research 511–540 of 1000+
- Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases
- Investigation and Analysis on Correlational Factors and Constitution of Traditional Chinese Medicine of Androgenetic Alopecia
- Androgenetic alopecia treatment options are plentiful
- 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
- Analysis Polymorphism of Androgen Receptor in Cases of Androgenetic Alopecia
- Androgenetic alopecia
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- A genetic test for androgenetic alopecia: polymorphisms in the androgen receptor gene provide a genetic screening test for androgenetic alopecia and earlier medical intervention
- The involvement of ROS on androgen inducible TGF beta 1 regulation derived from dermal papilla cells; a suggestive implication of ROS on androgenetic alopecia
- Genetic Markers of Male and Female Pattern Hair Loss
- Androgenetic alopecia
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- The risk of coronary heart disease in men with androgenetic alopecia
- Recent Advances in Hair Biology and in Treatments of Androgenetic Alopecia.
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men
- Male-pattern baldness susceptibility locus at 20p11
- Male pattern hair loss: current understanding
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment
- Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- 2% Topical Minoxidil Solution in Male-Pattern Baldness: Preliminary European Results
- A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness
- Controversy: is there a role for adjuvants in the management of male pattern hair loss?
- t-Flavanone Improves the Male Pattern of Hair Loss by Enhancing Hair-Anchoring Strength: A Randomized, Double-Blind, Placebo-Controlled Study
- Use of body and beard donor hair in surgical treatment of androgenic alopecia
- Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness